Lidocaine; tetracaine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for lidocaine; tetracaine and what is the scope of freedom to operate?
Lidocaine; tetracaine
is the generic ingredient in two branded drugs marketed by Crescita Therap and Galen Specialty, and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Lidocaine; tetracaine has seven patent family members in seven countries.
Three suppliers are listed for this compound.
Summary for lidocaine; tetracaine
International Patents: | 7 |
US Patents: | 3 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Clinical Trials: | 61 |
DailyMed Link: | lidocaine; tetracaine at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for lidocaine; tetracaine
Generic Entry Date for lidocaine; tetracaine*:
Constraining patent/regulatory exclusivity:
Dosage:
CREAM;TOPICAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for lidocaine; tetracaine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Juerg Hafner | Phase 2 |
Cutia Therapeutics(Wuxi)Co.,Ltd | Phase 3 |
Kalpna Kay Durairaj, MD, FACS | Phase 1 |
Pharmacology for lidocaine; tetracaine
Drug Class | Amide Local Anesthetic Antiarrhythmic Ester Local Anesthetic |
Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for lidocaine; tetracaine
US Patents and Regulatory Information for lidocaine; tetracaine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crescita Therap | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Crescita Therap | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Crescita Therap | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for lidocaine; tetracaine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Crescita Therap | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for lidocaine; tetracaine
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2012008168 | FORMULACIONES ANESTESICAS LOCALES QUE FORMAN SOLIDOS PARA CONTROL DEL DOLOR. (SOLID-FORMING LOCAL ANESTHETIC FORMULATIONS FOR PAIN CONTROL.) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2011088333 | ⤷ Sign Up | |
Australia | 2011205730 | Solid-forming local anesthetic formulations for pain control | ⤷ Sign Up |
European Patent Office | 2523660 | FORMULATIONS POUR ANESTHÉSIE LOCALE SE SOLIDIFIANT POUR LA GESTION DE LA DOULEUR (SOLID-FORMING LOCAL ANESTHETIC FORMULATIONS FOR PAIN CONTROL) | ⤷ Sign Up |
Brazil | 112012017554 | formulações de anestésicas locais formadoras de sólido para controle da dor | ⤷ Sign Up |
China | 102834096 | Solid-forming local anesthetic formulations for pain control | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.